Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11226685 | PMC |
| http://dx.doi.org/10.1007/s00262-024-03727-0 | DOI Listing |
Publication Analysis
Top Keywords
correction ceacam-targeting
4
ceacam-targeting 2a3
4
2a3 single-domain
4
single-domain antibody-based
4
antibody-based chimeric
4
chimeric antigen
4
antigen receptor
4
receptor t-cells
4
t-cells produce
4
produce anticancer
4
Similar Publications
Correction to: New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo.
Cancer Immunol Immunother
July 2024
4Cell Therapies S.A., 59C Bojkowska Street, 44-100, Gliwice, Poland.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!